AbstractHere we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Biomarkers in lung cancer / BEARZ A; BERRETTA M; CAPPELLANI A; LLESHI A; BERTO E; FRATINO L; TIRELLI U. - In: FRONTIERS IN BIOSCIENCE. - ISSN 1093-9946. - 2(2010), pp. 1099-1104.
Titolo: | Biomarkers in lung cancer |
Autori interni: | |
Data di pubblicazione: | 2010 |
Rivista: | |
Citazione: | Biomarkers in lung cancer / BEARZ A; BERRETTA M; CAPPELLANI A; LLESHI A; BERTO E; FRATINO L; TIRELLI U. - In: FRONTIERS IN BIOSCIENCE. - ISSN 1093-9946. - 2(2010), pp. 1099-1104. |
Handle: | http://hdl.handle.net/20.500.11769/6849 |
Appare nelle tipologie: | 1.1 Articolo in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.